Idexx Laboratories
IDXX
482 hedge funds and large institutions have $9.21B invested in Idexx Laboratories in 2016 Q3 according to their latest regulatory filings, with 69 funds opening new positions, 148 increasing their positions, 188 reducing their positions, and 20 closing their positions.
245% more first-time investments, than exits
New positions opened: 69 | Existing positions closed: 20
29% more funds holding in top 10
Funds holding in top 10: 14 → 18 (+4)
20% more capital invested
Capital invested by funds: $7.7B → $9.21B (+$1.52B)
10% more funds holding
Funds holding: 437 → 482 (+45)
21% less repeat investments, than reductions
Existing positions increased: 148 | Existing positions reduced: 188
48% less call options, than puts
Call options by funds: $9.22M | Put options by funds: $17.9M
Top Buyers
| 1 |
Arrowstreet Capital
Boston,
Massachusetts
|
+$29.7M |
| 2 |
JHIU
Janus Henderson Investors US
Denver,
Colorado
|
+$26.8M |
| 3 |
Prudential Financial
Newark,
New Jersey
|
+$25.2M |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$23.8M |
| 5 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
+$20.4M |
Top Sellers
| 1 |
Select Equity Group
New York
|
-$76.3M |
| 2 |
CIC
Chilton Investment Company
Stamford,
Connecticut
|
-$39.1M |
| 3 |
Goldman Sachs
New York
|
-$31.6M |
| 4 |
ACM
Atlanta Capital Management
Atlanta,
Georgia
|
-$28.9M |
| 5 |
William Blair Investment Management
Chicago,
Illinois
|
-$23.3M |
IDXX Hedge Fund Activity: Q3 2016 in Review
482 of the 3,748 institutional investors tracked by Wall St. Rank reported a position in Idexx Laboratories (IDXX) for Q3 2016, worth a combined $9.21B — up 20% from $7.7B a quarter earlier.
Buyers outnumbered sellers: 69 funds opened new IDXX positions and 20 closed out — a net gain of 49 holders — while 148 added to existing stakes and 188 trimmed.
The largest buyer was Arrowstreet Capital, adding an estimated $29.7M. The largest seller was Select Equity Group, cutting an estimated $76.3M.
- 482 institutional investors held Idexx Laboratories (IDXX) as of Q3 2016, up from 437 in Q2 2016.
- Funds reported $9.21B of Idexx Laboratories stock for Q3 2016, up 20% quarter-over-quarter.
- 69 funds opened new Idexx Laboratories positions in Q3 2016 and 20 closed out, a net change of +49 holders.
- The largest Idexx Laboratories buyer in Q3 2016 was Arrowstreet Capital, an estimated $29.7M added.
- The largest Idexx Laboratories seller in Q3 2016 was Select Equity Group, an estimated $76.3M sold.
Based on aggregated 13F filings for Q3 2016.